173.809 articles found

Exercise modality and planned weekly exercise exposure for motor outcomes in Parkinson's disease: a systematic review, Bayesian network meta-analysis, and meta-regression.

Wang L, Wang H, Hong F, Wan Z.

J Neurol · 2026-10-10

DOI: 10.1007/s00415-026-14189-yPMID: 42859236

Olive leaf-derived exosome-like vesicles attenuate neurotoxicity in an in vitro rotenone model of Parkinson's disease.

Sahsahi A, Degirmenci NS, Aydın M, Şahin F, Işık S.

Metab Brain Dis · 2026-10-10

DOI: 10.1007/s11011-026-01990-xPMID: 42859260

The Gut-Brain Axis and Neurodegenerative Diseases: From Mechanistic Pathways to Therapeutic Interventions.

Lin W, Shu Z, Liu G, Fang J, Ding S.

Probiotics Antimicrob Proteins · 2026-10-10

DOI: 10.1007/s12602-026-11246-wPMID: 42859348

A dual-mode surface-enhanced Raman scattering and piezoresistive sensing platform for biomolecular and biomechanical analysis in Parkinson's disease.

Chen D, Gao J, Ma Z, Jiang W, Ren X, Shi Y, Liu H, Zhang M, Fan W.

Biosens Bioelectron · 2026-10-10

DOI: 10.1016/j.bios.2026.119328PMID: 42868738

α-Synuclein pathology induces conserved lipid acyl-chain remodeling across mouse brain and human dopaminergic neurons

Dinter E, Szegö ÉM, Luksch H, Höfs L, Falkenburger BH.

· 2026-10-09

DOI: 10.21203/rs.3.rs-11097164/v1

AGMNet: an explainable gated multimodal framework integrating MRI heterogeneity and dopaminergic asymmetry for Parkinson's disease classification

Abinaya T, Sivashankari R.

Frontiers in artificial intelligence · 2026-10-09

Effectiveness and safety of theta burst stimulation for Parkinson's disease: an updated systematic review and meta-analysis of randomized parallel-group controlled trials

Xu Q, Hao S, Wang Y, Xi W, Li Y, Wang Y.

Frontiers in neurology · 2026-10-09

Comparison of automated white matter lesion segmentation approaches for use in large, multi-site data analyses in Parkinson’s disease

Al-Bachari S, Yoon S, Emson P, Angell S, Cain J, Abraham A, Chughtai A, Sizer E, Barnes E, Al-Wardy M, Kannan S, Paul-Thaper R, Bright J, Owens-Walton C, McMillan C, Klein J, Griffanti L, Thomopoulos S, Jahanshad N, Thompson P, van der Werf Y, Vriend C, Parkes L, Emsley H, Schrag A, Haroon H.

Frontiers in neuroscience · 2026-10-09

The clinical value of combined assessment of substantia nigra morphology and intracranial hemodynamics via transcranial ultrasound in the diagnosis and differentiation of Parkinson’s disease

Liang L, Cui Q.

Frontiers in neurology · 2026-10-09

The Relationship of Peripheral Glycoprotein Nonmetastatic Melanoma Protein B and Parkinson's Disease: Insights From a Mendelian Randomization Study.

Zhang Y, Huang E, Lin N.

Int J Genomics · 2026-10-09

DOI: 10.1155/ijog/2340381PMID: 42857676

Polysomnographic and nocturnal heart rate correlates of cognitive impairment in Parkinson's disease: a cross-sectional study.

Linwei Z, Pu L, Lu W, Xiangfei Z, Kang W, Miao J.

Front Neurol · 2026-10-09

DOI: 10.3389/fneur.2026.1913495PMID: 42920474

Long-term trends in selected neurological disorders in Italy (1990-2023): analysis of the global burden of disease (GBD) 2023 data.

Brigo F, Turcato G, Zaboli A, Lattanzi S.

Neurol Sci · 2026-10-09

DOI: 10.1007/s10072-026-09457-8PMID: 42850460